IGM Biosciences (IGMS) EV/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EV/EBITDA | ? | -2.73 | -28.3 | -4.73 | -1.41 | -0.54 | -0.13 | ||
Changes by years, y/y, % | +1 856% | +939% | -83% | -70% | -62% | +30.9% |
IGM Biosciences. EV/EBITDA
IGM Biosciences. EV/EBITDA, changes, %
IGM Biosciences (IGMS) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EV/EBITDA | ? | -1.19 | -0.29 | -0.60 | -0.77 | -1.31 | -0.13 | |
Changes by years, y/y, % | -71% | -81% | -77% | -53% | +10% | |||
Changes by quarters, q/q, % | -27% | -75% | +107% | +28% | +69% |